PMVP - PMV Pharmaceuticals, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.42 0.05 (3.27%) --- --- --- 0.04 (2.82%) 0.03 (1.76%) 0.05 (3.27%) 0.05 (3.27%)

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.41
Diluted EPS:
-0.41
Basic P/E:
-3.5766
Diluted P/E:
-3.5766
RSI(14) 1m:
58.0
VWAP:
1.46
RVol:
1.2094

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.43 -0.01 (-1.04%) Oct 15 15:42
1m Price decrease 1m 1.43 -0.02 (-1.04%) Oct 15 14:56
1m Price increase 1m 1.44 +0.02 (+1.41%) Oct 15 14:18
1m Price decrease 1m 1.4 -0.02 (-1.41%) Oct 15 14:12
1m Price decrease 1m 1.4 -0.02 (-1.58%) Oct 15 12:49

Related News